Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Vaccine|December 4, 2004
A humanized monoclonal antibody targeting Staphylococcus aureusJoseph M PattiExpert Opinion on Investigational Drugs|June 4, 2004
Immunotherapeutics for nosocomial infectionsJoseph M PattiMicrobes and Infection|March 5, 2004
Expression of staphylococcal clumping factor A impedes macrophage phagocytosisNiklas Palmqvist, Joseph M Patti, Andrzej Tarkowski, et al.Current Opinion in Drug Discovery & Development|December 18, 2004
MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infectionJorge M Rivas, Pietro Speziale, Joseph M Patti, et al.Antimicrobial Agents and Chemotherapy|February 25, 2005
Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteersSandra Reilley, Eric Wenzel, Laurie Reynolds, et al.Antimicrobial Agents and Chemotherapy|September 29, 2006
Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysisSeth Hetherington, Michele Texter, Eric Wenzel, et al.Infection and Immunity|October 27, 2004
SdrX, a serine-aspartate repeat protein expressed by Staphylococcus capitis with collagen VI binding activityYule Liu, Brenda Ames, Elena Gorovits, et al.Infection and Immunity|May 24, 2005
Role of Staphylococcus aureus global regulators sae and sigmaB in virulence gene expression during device-related infectionChristiane Goerke, Ursula Fluckiger, Andrea Steinhuber, et al.Antimicrobial Agents and Chemotherapy|March 30, 2011
Pharmacokinetics and safety of FV-100, a novel oral anti-herpes zoster nucleoside analogue, administered in single and multiple doses to healthy young adult and elderly adult volunteersHelen S Pentikis, Mark Matson, George Atiee, et al.Antimicrobial Agents and Chemotherapy|January 27, 2006
Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivoJohn H Vernachio, Arnold S Bayer, Brenda Ames, et al.Pageof 2